• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inhaled beta 2-adrenergic agonists in asthma. The Executive Committee of the American Academy of Allergy and Immunology.

出版信息

J Allergy Clin Immunol. 1993 Jun;91(6):1234-7.

PMID:8099595
Abstract
摘要

相似文献

1
Inhaled beta 2-adrenergic agonists in asthma. The Executive Committee of the American Academy of Allergy and Immunology.哮喘中吸入性β2肾上腺素能激动剂。美国过敏与免疫学会执行委员会。
J Allergy Clin Immunol. 1993 Jun;91(6):1234-7.
2
Inhaled beta-agonist use and life-threatening asthma.
Am J Respir Crit Care Med. 1995 Jul;152(1):414. doi: 10.1164/ajrccm.152.1.7599860.
3
Present state of the controversy about regular inhaled beta-agonists in asthma.
Eur Respir J. 1995 May;8(5):673-8.
4
Questions about inhaled beta 2-adrenoceptor agonists in asthma.关于哮喘中吸入性β2肾上腺素能受体激动剂的问题。
Trends Pharmacol Sci. 1992 Jan;13(1):20-3. doi: 10.1016/0165-6147(92)90011-t.
5
[Increased asthma fatality in chronic administration of beta agonists?].[长期使用β受体激动剂会增加哮喘死亡率吗？]
Dtsch Med Wochenschr. 1993 Feb 12;118(6):206-7.
6
Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthma.
Respir Med. 1992 Nov;86(6):471-6. doi: 10.1016/s0954-6111(96)80004-7.
7
An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.吸入皮质类固醇治疗哮喘患者中长效β-激动剂的安全性更新。
Expert Opin Drug Saf. 2010 May;9(3):407-19. doi: 10.1517/14740330903535852.
8
Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.长效β-激动剂联合或不联合吸入性皮质类固醇与灾难性哮喘事件。
Am J Med. 2010 Apr;123(4):322-8.e2. doi: 10.1016/j.amjmed.2009.07.035. Epub 2010 Feb 20.
9
Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.哮喘治疗中吸入性β2肾上腺素能激动剂：不断演变的困境
Singapore Med J. 1994 Jun;35(3):237-9.
10
Long-acting inhaled beta agonists.长效吸入型β受体激动剂
J Asthma. 1995;32(6):397-404. doi: 10.3109/02770909409077750.

引用本文的文献

1
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.用于成人和儿童慢性哮喘的长效β2受体激动剂，其背景治疗包含不同种类或不包含吸入性糖皮质激素。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001385. doi: 10.1002/14651858.CD001385.pub2.
2
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.长效β受体激动剂常规治疗与短效β受体激动剂每日常规治疗用于稳定期哮喘成人和儿童的比较
Cochrane Database Syst Rev. 2002;2002(4):CD003901. doi: 10.1002/14651858.CD003901.
3
Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.
吸入性短效β2受体激动剂在哮喘治疗中的应用：规律治疗与按需治疗
Cochrane Database Syst Rev. 2000;2003(4):CD001285. doi: 10.1002/14651858.CD001285.
4
Long- versus short-acting beta 2-agonists. Implications for drug therapy.长效与短效β2受体激动剂。对药物治疗的影响。
Drugs. 1994 Feb;47(2):207-22. doi: 10.2165/00003495-199447020-00001.